Weight Loss

The disease of obesity often brings cardiometabolic consequences, including hypertension, which remains the most potent and predictive risk factor for cardiovascular disease.

CHICAGO — There is no harm in adding wild blueberries to a weight-loss regimen — in fact, they may even help to curb food cravings and preserve lean body mass, according to results of a small, randomized study presented at NUTRITION.

Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal Medicine.

Published results showed exercise in combination with glucagon-like peptide-1 receptor agonist treatment may be an effective weight loss strategy that preserves clinically relevant site-specific bone mineral density.

A 5:2 intermittent fasting diet combined with meal replacement resulted in greater weight loss and better glycemic control compared with antidiabetic medications in patients with early-stage type 2 diabetes, data from the EARLY study showed.

ORLANDO — Among adults with obesity-related heart failure with preserved ejection fraction, women taking semaglutide lost significantly more weight than men, but greater weight loss did not result in extra health benefits for women vs. men.

ORLANDO — Adults with obesity who reduce their body weight lower their odds for developing an obesity-related cancer, according to data presented at the American Diabetes Association Scientific Sessions.

Following a weight reduction surgery/procedure, adults with obesity and obstructive sleep apnea lost weight and had decreased positive airway pressure, according to research presented at SLEEP 2024.

PHILADELPHIA — In this Healio video exclusive, Neha J. Pagidipati, MD, MPH, highlights growing evidence on the relationship between weight change and risk for cardiovascular disease.